Home / Industry / Manufacturing / India's Hetero wins emergency use nod to make Roche's Covid drug

India's Hetero wins emergency use nod to make Roche's Covid drug

A sign at a diagnostics site for Swiss pharmaceutical giant Roche. (REUTERS) — A sign at a diagnostics site for Swiss pharmaceutical giant Roche. **(REUTERS)**

1 min read . Updated: 06 Sep 2021, 01:32 PM IST Shivani Singh, Reuters

Indian drug developer Hetero said that it has received emergency use approval to make a generic version of Roche Holding AG's COVID-19 drug

BENGALURU: Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to Mint Newsletters

* Enter a valid email

* Thank you for subscribing to our newsletter.

Edit Profile

Get alerts on WhatsApp

Set Preferences My Reads Feedback Redeem a Gift Card Logout

India's Hetero wins emergency use nod to make Roche's Covid drug

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue